Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding corevalve prosthesis : Device success and 30-day clinical outcome

We sought to determine both the procedural performance and safety of percutaneous implantation of the second (21-French [F])- and third (18-F)-generation CoreValve aortic valve prosthesis (CoreValve Inc., Irvine, California). Percutaneous aortic valve replacement represents an emerging alternative t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2007-07, Vol.50 (1), p.69-76
Hauptverfasser:	GRUBE, Eberhard, SCHULER, Gerhard, IVERSEN, Stein, FELDERHOFF, Thomas, CARTIER, Raymond, BONAN, Raoul, BUELLESFELD, Lutz, GERCKENS, Ulrich, LINKE, Axel, WENAWESER, Peter, SAUREN, Barthel, MOHR, Friedrich-Wilhelm, WALTHER, Thomas, ZICKMANN, Bernfried
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Aged, 80 and over Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - mortality Aortic Valve Stenosis - therapy Biological and medical sciences Bioprosthesis Cardiac Catheterization Cardiology Cardiology. Vascular system Coronary vessels Female Follow-Up Studies Heart attacks Heart Valve Prosthesis Implantation - methods Heart Valve Prosthesis Implantation - mortality Humans Male Medical sciences Mortality Orthopedic surgery Prospective Studies Prosthesis Design Risk Assessment Severity of Illness Index Single-Blind Method Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!